MuRF1 Partners With TRIM72 to Impair Insulin Signaling in Skeletal Muscle Cells
Ibrahim Musa1,2, Alex Peter Seabright1, Jonathan Barlow1,3
1School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, UK.
Abstract:
Muscle RING-finger protein 1 (MuRF1, gene name: TRIM63) is well known as a critical molecular regulator in skeletal muscle atrophy. Despite the identification of several substrates and interaction partners for MuRF1, the precise molecular mechanisms by which MuRF1 causes skeletal muscle atrophy remain unclear. To gain further insight into the underlying mechanism of skeletal muscle atrophy, we applied targeted biochemical approaches and identified tripartite motif-containing protein 72 (TRIM72) as a novel MuRF1-interacting protein. Subsequent analysis using MuRF1 knockout and rescue experiments showed that TRIM72 protein abundance is dependent on the presence of MuRF1 protein. Furthermore, TRIM72 protein level was increased by dexamethasone treatment in C2C12 myotubes, alongside increased MuRF1 protein level. Dexamethasone decreases IRS1/Akt signaling and glucose uptake specifically in wild type myotubes, but not in MuRF1 KO myotubes. Further analysis showed that overexpression of TRIM72 impairs IRS1/Akt signaling without the presence of MuRF1, indicating that MuRF1 induces a negative impact on insulin signaling through a plausible cooperation with TRIM72. Our findings provide novel non-degradative molecular roles of MuRF1 that link together skeletal muscle atrophy and impaired insulin sensitivity.
Insights
Muscle RING-finger protein 1 (MuRF1) interacts with TRIM72, impacting skeletal muscle atrophy and insulin sensitivity. This study reveals non-degradative roles for MuRF1 in muscle wasting and metabolic dysfunction.
Area of Science:
- Biochemistry
- Molecular Biology
- Physiology
Background:
- Muscle RING-finger protein 1 (MuRF1, TRIM63) is a key regulator of skeletal muscle atrophy.
- The exact molecular mechanisms by which MuRF1 induces muscle atrophy are not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying MuRF1-mediated skeletal muscle atrophy.
- To identify novel MuRF1 interaction partners and their roles in muscle physiology.
Main Methods:
- Targeted biochemical approaches to identify MuRF1 interactors.
- MuRF1 knockout and rescue experiments in C2C12 myotubes.
- Dexamethasone treatment to induce atrophy markers.
- Analysis of insulin signaling pathways (IRS1/Akt) and glucose uptake.
Main Results:
- Tripartite motif-containing protein 72 (TRIM72) was identified as a novel MuRF1-interacting protein.
- TRIM72 protein abundance is dependent on MuRF1 presence and increased by dexamethasone.
- MuRF1 and TRIM72 cooperate to impair insulin signaling (IRS1/Akt) and glucose uptake, particularly in wild-type myotubes.
Conclusions:
- MuRF1 plays non-degradative roles in skeletal muscle atrophy.
- MuRF1, potentially through cooperation with TRIM72, contributes to impaired insulin sensitivity in muscle.
- These findings link skeletal muscle atrophy and metabolic dysfunction at a molecular level.
More Related Videos
08:01Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
Published on: May 16, 2021
08:03Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Insulin: The Receptor and Signaling Pathways
